FDA approves two new gene therapies for sickle cell disease

FDA approves two new gene therapies for sickle cell disease

The U.S. Food and Drug Administration (FDA) on Friday announced that it has approved Casgevy, the first CRISPR gene-editing therapy for sickle cell disease, paving the way for thousands of patients i… [+5360 chars]

Read More
Top